Public Health | March 08, 2022
GOQii survey points to rise in women medical issues
Women's health is in fact a direct reflection of the nation's overall health
Women's health is in fact a direct reflection of the nation's overall health
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
Company expects strong organic growth in sales, EBITDA in 2022
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
It is used to control, prevent and normalize the symptoms associated with Alzheimer's disease, attention disorder, bipolar disorder, Parkinson's disease among others
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
Laglo Soft lotion comes with a unique technology that enhances moisturisation and restructures the skin
NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction
Subscribe To Our Newsletter & Stay Updated
